p53: From Fundamental Biology to Clinical Applications in Cancer

p53: From Fundamental Biology to Clinical Applications in Cancer

p53 tumour suppressor gene is our major barrier against neoplastic transformation. It is involved in many cellular functions, including cell cycle arrest, senescence, DNA repair, apoptosis, autophagy, cell metabolism, ferroptosis, immune system regulation, generation of reactive oxygen species, mito...

Full description

Bibliographic Details
Main Authors:	Maurizio Capuozzo, Mariachiara Santorsola, Marco Bocchetti, Francesco Perri, Marco Cascella, Vincenza Granata, Venere Celotto, Oreste Gualillo, Alessia Maria Cossu, Guglielmo Nasti, Michele Caraglia, Alessandro Ottaiano
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Biology
Subjects:	p53 tp53 cancer DNA repair tumour progression
Online Access:	https://www.mdpi.com/2079-7737/11/9/1325

Similar Items

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
by: Alessandro Ottaiano, et al.
Published: (2023-01-01)

Editorial: Type 2 diabetes and cancer: clinical and molecular interactions
by: Mariachiara Santorsola, et al.
Published: (2024-01-01)

Immunohistochemical Expression of Ki67 and p53 in Primary Breast Carcinoma and Combined Ki67-p53 Status Phenotypes in Hormone Receptor Positive Breast Carcinoma
by: Rishiraj Baruah, et al.
Published: (2020-03-01)

Exploring the multiple roles of guardian of the genome: P53
by: Wasim Feroz, et al.
Published: (2020-11-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

Development of mouse models of angiosarcoma driven by p53
by: Donald M. Salter, et al.
Published: (2019-07-01)

Clinicohistopathological Features and Immunohistochemical Expression Patterns of p53 in Epithelial Ovarian Tumours: A Cross-sectional Study
by: Ruby Jaiswal, et al.
Published: (2024-01-01)

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease
by: Giulia Abate, et al.
Published: (2020-12-01)

Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes
by: Victoria L. Haley, et al.
Published: (2012-06-01)

P53 mRNA in- Situ Hybridization analysis and Immunohistochemical Expression in Lung Cancer: A Comparative Study.
by: Ban A. Abdul-Majeed
Published: (2010-10-01)

Pyrimidine Triones as Potential Activators of p53 Mutants
by: Maryam M. Jebril Fallatah, et al.
Published: (2024-08-01)

The Status of p53 Oligomeric and Aggregation States in Cancer
by: Guilherme A. P. de Oliveira, et al.
Published: (2020-04-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

P53 marker expression in epithelial ovarian tumours in a centre in Nigeria – a descriptive study
by: Andrew Olushola Anjorin, et al.
Published: (2024-12-01)

p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53
by: Maria Anele Romeo, et al.
Published: (2021-02-01)

Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes
by: Lev Zavileyskiy, et al.
Published: (2022-02-01)

STAT3 and p53: Dual Target for Cancer Therapy
by: Thu-Huyen Pham, et al.
Published: (2020-12-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
by: Wenshu Li, et al.
Published: (2024-07-01)

Detection of p53 mutation and serum monitoring alert caused by Marek’s disease virus in poultry
by: Huixia Zhang, et al.
Published: (2020-08-01)

Identification of p53 gene alterations in canine mammary tumours using polymerase chain reaction and direct sequence analysis
by: R. J. Jozani, et al.
Published: (2020-09-01)

Tumor protein 53-induced nuclear protein 1 (TP53INP1) enhances p53 function and represses tumorigenesis
by: Jeyran eShahbazi, et al.
Published: (2013-05-01)

Regulation of Metabolic Activity by p53
by: Jessica Flöter, et al.
Published: (2017-05-01)

TP53 and c-myc Co-alterations: A hallmark of oral cancer progression
by: Tanić Nasta, et al.
Published: (2013-01-01)

Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles
by: Lixian Oh, et al.
Published: (2020-02-01)

Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
by: Eun Young Kang, et al.
Published: (2022-01-01)

Insights into the Effect of the G245S Single Point Mutation on the Structure of p53 and the Binding of the Protein to DNA
by: Marco Gaetano Lepre, et al.
Published: (2017-08-01)

Che-1/AATF: a critical co-factor for both wild type- and mutant-p53 proteins
by: Tiziana eBruno, et al.
Published: (2016-02-01)

Childhood Adrenocortical Tumours: a Review
by: Marques-Pereira Rosana, et al.
Published: (2006-05-01)

Wilms′ tumour: Determinants of prognosis in an African setting
by: Akinfenwa Taoheed Atanda, et al.
Published: (2015-01-01)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)

Recent Synthetic Approaches towards Small Molecule Reactivators of p53
by: Jerson L. Silva, et al.
Published: (2020-04-01)

Chemical Variations on the p53 Reactivation Theme
by: Carlos J. A. Ribeiro, et al.
Published: (2016-05-01)

Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo
by: Takatsune Shimizu, et al.
Published: (2022-11-01)

Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology
by: Li Qi, et al.
Published: (2024-07-01)

COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
by: Alessandro Ottaiano, et al.
Published: (2021-03-01)

C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo
by: Robert L. Fine, et al.
Published: (2023-01-01)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
by: Shengliang Zhang, et al.
Published: (2022-04-01)

Immunohistochemical detection of p53 and pp53 Ser392 in canine hemangiomas and hemangiosarcomas located in the skin
by: María José García-Iglesias, et al.
Published: (2020-07-01)